• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人促甲状腺素在大剂量放射性碘治疗中的价值:病例报告

Value of recombinant human thyrotropin in high-dose radioiodine therapy: a case report.

作者信息

Müller Vika, Bohuslavizki Karl H, Klutmann Susanne, Clausen Malte

机构信息

Department of Nuclear Medicine, University Hospital Eppendorf, Hamburg, Germany.

出版信息

J Nucl Med Technol. 2002 Dec;30(4):185-8.

PMID:12446752
Abstract

We report on a high-dose radioiodine therapy after injection of recombinant human thyrotropin (rhTSH) in a 61-y-old woman with compression of the spinal cord caused by metastasis of a follicular thyroid carcinoma. Fourteen years ago, the patient underwent subtotal thyroidectomy because of multinodular goiter without any histologic evidence for malignant disease, and the patient was put on thyroxine substitution (100 micro g/d). In April 2000, she developed paralysis of the right leg. Morphologic imaging revealed spinal compression caused by a space-occupying lesion within the thoracic spine. Subsequent biopsy and histology demonstrated metastasis of a follicular thyroid carcinoma. Therefore, high-dose radioiodine therapy was scheduled after 4 wk of hormone withdrawal. Within a few days of being off thyroxine, the patient's paralytic symptoms worsened rapidly. The patient was again put on thyroxine, 100 micro g/d, and high-dose radioiodine therapy under stimulation with rhTSH was performed without any side effects. The second high-dose radioiodine therapy 3 mo later, again performed under stimulation with rhTSH, showed significantly less iodine avidity, and thyroglobulin levels fell from 1,024 micro g/L to 361 micro g/L, thereby demonstrating therapeutic efficacy. Thus, rhTSH might be used as a tool not only in the diagnostic application but also in the therapeutic application of (131)I.

摘要

我们报告了一例61岁女性滤泡状甲状腺癌转移导致脊髓受压患者,在注射重组人促甲状腺素(rhTSH)后接受大剂量放射性碘治疗的病例。14年前,该患者因结节性甲状腺肿接受了甲状腺次全切除术,当时无任何恶性疾病的组织学证据,术后患者接受甲状腺素替代治疗(100μg/d)。2000年4月,她出现右腿麻痹。形态学影像显示胸椎内占位性病变导致脊髓受压。随后的活检及组织学检查证实为滤泡状甲状腺癌转移。因此,在激素停用4周后安排了大剂量放射性碘治疗。在停用甲状腺素的几天内,患者的麻痹症状迅速恶化。患者再次接受100μg/d的甲状腺素治疗,并在rhTSH刺激下进行大剂量放射性碘治疗,未出现任何副作用。3个月后在rhTSH刺激下再次进行第二次大剂量放射性碘治疗,结果显示碘摄取明显减少,甲状腺球蛋白水平从1024μg/L降至361μg/L,从而证明了治疗效果。因此,rhTSH不仅可作为一种工具用于(131)I的诊断应用,也可用于治疗应用。

相似文献

1
Value of recombinant human thyrotropin in high-dose radioiodine therapy: a case report.重组人促甲状腺素在大剂量放射性碘治疗中的价值:病例报告
J Nucl Med Technol. 2002 Dec;30(4):185-8.
2
rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.甲状腺癌放射性碘治疗前使用重组人促甲状腺素刺激会缩短碘-131的有效半衰期。
J Nucl Med. 2003 Jul;44(7):1065-8.
3
Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.单次低剂量重组人促甲状腺激素预处理后结节性甲状腺肿患者放射性碘治疗的剂量学
J Nucl Med. 2004 Apr;45(4):626-33.
4
Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.甲状腺癌患者在甲状腺激素剥夺状态下及使用重组人促甲状腺素时肿瘤组织与非肿瘤组织碘摄取情况的比较。
Clin Endocrinol (Oxf). 2006 Oct;65(4):519-23. doi: 10.1111/j.1365-2265.2006.02626.x.
5
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.重组人促甲状腺素辅助放射性碘消融及分化型甲状腺癌的治疗:综述
Endocr Relat Cancer. 2005 Mar;12(1):49-64. doi: 10.1677/erc.1.00830.
6
Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy.放射性碘治疗前使用重组人促甲状腺素对转移性分化型甲状腺癌患者进行肿瘤剂量测定及反应研究
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):367-73. doi: 10.1007/s00259-002-1076-y. Epub 2002 Dec 19.
7
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.甲状腺癌放射性碘治疗中的碘生物动力学与剂量学:促甲状腺激素释放激素(rhTSH)或激素撤减后消融的前瞻性国际对照研究的程序与结果
J Nucl Med. 2006 Apr;47(4):648-54.
8
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.重组人促甲状腺素辅助放射性碘残留消融术的短期临床复发率与传统甲状腺激素撤药法相似。
J Nucl Med. 2008 May;49(5):764-70. doi: 10.2967/jnumed.107.049072. Epub 2008 Apr 15.
9
Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.重组人促甲状腺素辅助给予分化型甲状腺癌患者放射性碘剂量的效用。
Medicina (B Aires). 2006;66(2):125-30.
10
High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.在患有多结节性甲状腺肿和亚临床/临床甲状腺功能亢进的患者中,使用30毫居里重组人促甲状腺素刺激放射性碘治疗后副作用的高发生率。
Thyroid. 2009 Sep;19(9):945-51. doi: 10.1089/thy.2008.0394.

引用本文的文献

1
Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.重组人促甲状腺激素在分化型甲状腺癌远处转移患者治疗中的潜在应用。
Endocr Pract. 2013 Jan-Feb;19(1):139-48. doi: 10.4158/EP12244.RA.
2
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.放射性碘治疗转移性甲状腺癌:甲状腺激素抑制与重组人促甲状腺激素制备的相对疗效和副作用特征。
Thyroid. 2012 Mar;22(3):310-7. doi: 10.1089/thy.2011.0235. Epub 2012 Feb 7.
3
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.
重组人促甲状腺素(rhTSH)辅助放射性碘治疗残留或转移性分化型甲状腺癌。
Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD008302. doi: 10.1002/14651858.CD008302.pub2.